Overview
Synthivan Tablets combine Atazanavir and Ritonavir, two antiretroviral agents used in the treatment of Human Immunodeficiency Virus (HIV) infection. Atazanavir is a protease inhibitor that prevents HIV replication by blocking the protease enzyme, while Ritonavir acts as a pharmacokinetic booster by increasing Atazanavir levels in the blood to enhance its effectiveness. This combination is a key component of combination antiretroviral therapy (ART).





